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The Free Radical Scavenger a-Phenyl-Tert-Butyl Nitrone Aggravates
Hippocampal Apoptosis and Learning Deficits in Experimental
Pneumococcal Meningitis
Jutta M. Loeffler, Ralph Ringer, Martin Hablu¨tzel,
Martin G. Ta¨uber, and Stephen L. Leib
Institute for Infectious Diseases, University of Bern,
Bern, Switzerland
The effect of adjuvant therapy with the radical scavenger a-phenyl-tert-butyl nitrone (PBN;
100 mg/kg given intraperitoneally every 8 h for 5 days) on brain injury and learning function
was evaluated in an infant rat model of pneumococcal meningitis. Meningitis led to cortical
necrotic injury (median, 3.97% [range, 0%–38.9%] of the cortex), which was reduced to a median
of 0% (range, 0%–30.9%) of the cortex ( ) by PBN. However, neuronal apoptosis inP ! .001
the hippocampal dentate gyrus was increased by PBN, compared with that by saline (median
score, 1.15 [range, 0.04–1.73] vs. 0.31 [range, 0–0.92]; ). Learning function 3 weeksP ! .001
after cured infection, as assessed by the Morris water maze, was decreased, compared with
that in uninfected control animals ( ). Parallel to the increase in hippocampal apoptosis,P ! .001
PBN further impaired learning in infected animals, compared with that in saline-treated ani-
mals ( ). These results contrast with those of an earlier study, in which PBN reducedP ! .02
cortical and hippocampal neuronal injury in group B streptococcal meningitis. Thus, in pneu-
mococcal meningitis, antioxidant therapy with PBN aggravates hippocampal injury and learn-
ing deficits.
Bacterial meningitis continues to be a devastating disease
with high mortality (5%–40%) and frequent neurologic se-
quelae. In a study of 130 children, assessed several years after
bacterial meningitis, 8.5% had major deficits ( , seizures,IQ ! 70
spasticity, or profound hearing loss) and a further 18.5%
showed minor deficits (IQ, 70–80) [1]. The most common causal
pathogen of bacterial meningitis is Streptococcus pneumoniae,
which accounts for about half the cases and has the highest
mortality and incidence of sequelae [2–4].
Impaired learning, in both humans and animals, can result
from damage to the hippocampus [5–7]. In a recent histopatho-
logic study of humans who died of bacterial meningitis, apoptosis
of granular cells in the dentate gyrus was shown [8]. Volumetric
measurements of the hippocampus by magnetic resonance re-
vealed unilateral and bilateral hippocampal atrophy in patients
who survived bacterial meningitis [9]. Apoptosis of granular cells
is a characteristic feature of bacterial meningitis in human disease
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and in several animal models of meningitis due to the most com-
mon pathogens, including S. pneumoniae, group B streptococci
(GBS), and Listeria monocytogenes [8, 10–12].
Neuronal damage during bacterial meningitis is caused by a
complex cascade of inflammatory mechanisms, in which the
production of reactive oxygen species (ROS) plays an important
part. Vascular reactivity, permeability of the blood-brain bar-
rier, and neurotoxicity of excitatory amino acids have been
linked to the production of ROS [10, 13–15]. ROS are released
by the host from stimulated granulocytes, macrophages, and
microglia, and S. pneumoniae has been shown to use pyruvate
oxidase to produce ROS [16]. Inflammatory cytokines are under
the control of transcription factors modulated by ROS [17–19].
In experimental bacterial meningitis, the presence of ROS has
been localized to the ventricular and subarachnoid space and
along penetrating cortical vessels [10].
Thus far, experimental evidence has identified antioxidants
as a promising approach for adjunctive therapy of bacterial
meningitis [13, 20]. a-phenyl-tert-butyl nitrone (PBN) reacts
with ROS to form stable adducts. It is evenly distributed among
a wide range of tissues and shows high concentrations in the
cerebrospinal fluid (CSF) because of its lipophilicity [21]. PBN
is nontoxic at the levels required for efficient scavenging of ROS
in the brain [10, 22]. In an infant rat model of GBS meningitis,
PBN effectively decreased oxidative injury and attenuated neu-
ronal injury in the cortex and hippocampus [10].
The aim of the present study was 2-fold. First, we evaluated
the neuroprotective efficacy of PBN in an infant rat model of
meningitis due to S. pneumoniae, because PBN proved to be
beneficial in GBS meningitis. Second, we determined whether
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Figure 1. Survival curves for rats with Streptococcus pneumoniae
meningitis, treated with a-phenyl-tert-butyl nitrone (PBN) or saline.
the extent of hippocampal apoptosis observed in the acute dis-
ease correlates with learning function in meningitis survivors
treated with PBN or saline.
Materials and Methods
Model of meningitis. Nursing Sprague-Dawley rat pups
( ) were infected on postnatal day 11 by intracisternal in-n p 117
jection with 10 mL of saline containing log10 cfu/mL6.40 5 0.14
S. pneumoniae ( ) by means of a 32-gauge needle, asmean 5 SD
described elsewhere [23, 24]. Infected animals were randomized for
treatment with PBN (Calbiochem), 100 mg/kg intraperitoneally
every 8 h ( ), or an equal volume (0.3 mL) of saline intra-n p 57
peritoneally every 8 h ( ), starting at the time of infection,n p 60
for a duration of 5 days. Noninfected animals ( ) were in-n p 38
jected intracisternally with 10 mL of sterile pyrogen-free saline and
also were randomized to receive PBN ( ) or saline ( ),n p 8 n p 30
as described above. Eighteen hours after intracisternal inoculation,
animals were weighed and assessed clinically. Clinical status was
scored as follows: 5, normal motor activity and animal turned
upright in !5 s when put on its back; 4, decreased spontaneous
activity but still turned upright in !5 s; 3, turned upright in 15 s;
2, did not turn upright; and 1, did not move. To document men-
ingitis, 10 mL of CSF was obtained by puncture of the cisterna
magna and was cultured quantitatively. Infected animals then were
treated with ceftriaxone (Roche Pharma), 100 mg/kg subcutane-
ously every 12 h for 4 days.
Histopathology. For histopathologic examination, 52 animals
(infected and PBN-treated, ; infected and saline-treated,n p 18
; uninfected and PBN-treated, ; uninfected and saline-n p 18 n p 8
treated, ) were evaluated at h ( ) aftern p 8 22.5 5 2.0 mean 5 SD
infection, as described elsewhere [23, 25]. The area of cortical brain
damage was calculated as a percentage of the total cortex in each
section and was expressed as the mean value per animal. Cells with
morphologic changes compatible with apoptosis were counted in
3 visual fields (3400) in each of the 4 blades of the dentate gyrus,
and the following scoring system was applied: 0–5 ; 6–20cells p 0
; 120 . An average score per animal was calcu-cells p 1 cells p 2
lated from all sections evaluated. All histopathologic evaluations
were done by an investigator who was unaware of the clinical,
microbiologic, and treatment data for the respective animal.
Assessment of learning function. For the water maze procedure,
a round gray tank 1.8 m in diameter (surface, 2.54 m2) and 0.7 m
in height, filled with water at a temperature of 24–267C to a depth
of 48 cm, was used. The water was darkened by the addition of
nontoxic food coloring. A video camera was fastened to the ceiling
above the center of the pool. Before the test, gross vestibulomotor
dysfunction of animals to be assessed in the water maze was ex-
cluded by use of a rotating rod. Rats were placed on a foam cylinder
(circumference, 22 cm), which was fastened to a motor with ad-
justable speed and was placed 20 cm above the table surface. Ani-
mals had to stay on the cylinder at different speeds (4, 8, 12, and
16 rpm) for >10 s, to qualify for the water maze test. For assess-
ment of learning function, swimming patterns of the rats were
registered with the video tracking system (Ethovision; Noldus In-
formation Technology). The water surface was virtually divided
into 4 inner quadrants and a periphery with a width of 18 cm. An
adjustable platform, measuring cm and covered with a16 3 13
black, rough mat, was placed in the center of the first quadrant
0.5 cm below the water surface. Four entry zones, situated each
between 2 quadrants, were marked outside the pool. Three posters
of m with different black-and-white patterns (horizontal0.6 3 0.3
stripes, diagonal stripes, and circles) were placed on 3 different
walls 0.5 m from the edge of the pool, to serve as visual cues. The
room was illuminated by indirect light from the ground.
Thirty-two-day-old survivors of meningitis (PBN-treated, n p
; saline-treated, ) and uninfected littermate controls (27 n p 31 n p
) were transferred to the experiment room, where they were given22
24 h to acclimatize in 12-h light/dark cycles; the light was switched
on at 8 a.m. Animals were provided with water and food ad libitum.
During days 1–4, animals performed 5 training trials per day,
with the invisible platform in a fixed position throughout the test.
Each rat was put into the water with its head directed toward the
wall of the tank. If an animal found the platform within 90 s, it
was allowed to stay on it for 15 s before it was returned to the
cage. If the rat did not find the platform within 90 s, it was guided
there by hand and was allowed to stay on it for 15 s. Between
trials, animals rested for 45 min. Entry zones were randomized
with a dice for each trial. Tracks were recorded by the video track-
ing system, with 5 samples per second. The total distance moved
and the time to reach the platform were documented for each trial.
Statistical methods. Bacterial titers in the CSF were compared
with the unpaired Student’s t test. Survival curves were analyzed
by use of the Kaplan-Meier method. Incidence of seizures, spon-
taneous death, and cortical injury were compared with Fisher’s
exact test. The score of hippocampal apoptosis was analyzed with
the Mann-Whitney U test. The clinical activity score and weight
at 18 h and before the water maze task were compared with 1-way
analysis of variance and the Newman-Keuls post hoc test for mul-
tiple comparison. Distance and time in the water maze task were
calculated with repeated-measures analysis of variance, and pair-
wise comparison was done with the Tukey-Kramer adjustment.
SAS version 8.0 (SAS Institute) software was used. wasP < .05
considered to be significant.
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Figure 2. Brain histopathology of infant rats with pneumococcal meningitis 22.5 h after infection (Nissl stain). A, Section of cortex and
underlying hippocampus, at 320 magnification. Cortex shows area of reduced neuronal density with wedge-shaped distribution (arrowheads).
Bar, 0.5 mm. B, Border between areas of reduced (left) and normal (right) neuronal density, at 3400 magnification. Bar, 25 mm. C, Section of
dentate gyrus, at 3200 magnification. Arrowheads, Apoptotic neurons in granule cell layer; bar, 100 mm. D, Apoptotic cells showing typical
condensed, fragmented nuclei (arrowheads), at 3400 magnification. Bar, 25 mm.
Results
Characteristics of disease. By 18 h after infection, all ani-
mals had meningitis, as evidenced by lethargy and growth of
S. pneumoniae from CSF. Treatment with PBN, compared with
treatment with sterile saline, had no effect on bacterial titers
in CSF ( , vs. log10 cfu/mL;mean 5 SD 7.42 5 1.06 7.56 5 0.87
not significant). The clinical score was a ofmean 5 SD
for PBN-treated animals versus for saline-4.1 5 0.6 3.9 5 0.6
treated animals (not significant). Uninfected animals weighed
a of g; infected and PBN-treated ani-mean 5 SD 30.3 5 3.7
mals weighed g; and infected and saline-treated ani-25.7 5 3.6
mals weighed g ( , each infected group vs.26.7 5 3.2 P ! .001
uninfected; not significant, infected and PBN-treated vs. in-
fected and saline-treated). Survival curves were similar in the
2 infected groups (figure 1), and spontaneous death occurred
in 23 of 57 PBN-treated animals and in 24 of 60 saline-treated
animals (not significant). Seizures were observed more fre-
quently in saline- than in PBN-treated animals (15 of 60 vs. 3
of 57; ). At the age of 32 days, uninfected control ani-P ! .005
mals weighed a of g; infected andmean 5 SD 138.0 5 12.7
PBN-treated animals weighed g; and infected and116.6 5 22.0
saline-treated animals weighed g ( , each115.6 5 24.4 P ! .001
infected group vs. uninfected; not significant, infected and PBN-
treated vs. infected and saline-treated).
Histopathology. Histopathologic aspects of cortical and
hippocampal injury are shown in figure 2. Cortical injury, de-
fined as reduced neuronal density with morphologic features of
necrosis, was seen in 83.3% of infected and saline-treated ani-
mals (median, 3.97% [range, 0%–38.9%] of the cortex). This
proportion was reduced to 22.2% of infected and PBN-treated
animals (median, 0% [range, 0%–30.9%] of the cortex; P !
; figure 3A). In contrast, apoptosis in the dentate gyrus was.001
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Figure 3. Effect of treatment with radical scavenger a-phenyl-tert-
butyl nitrone (PBN) on neuronal injury in infant rats with pneumo-
coccal meningitis. A, Histopathology at h after infection22.5 5 2
showed extensive cortical injury in 83.3% of infected and saline-treated
animals (median, 3.97% [range, 0%–38.9%] of cortex) but in only 22.2%
of animals treated with PBN (median, 0% [range, 0%–30.9%] of cortex;
). B, In contrast, treatment with PBN increased apoptotic neu-P ! .001
ronal injury in hippocampal dentate gyrus, compared with saline (me-
dian score, 1.15 [range, 0.04–1.73] vs. 0.31 [0–0.92]; ). Histo-P ! .001
pathology of uninfected animals (not shown) revealed neither cortical
nor hippocampal neuronal injury.
Figure 4. Assessment of learning function, by Morris water maze.
Plots of distance and time to reach platform. Data are .mean 5 SE
Analysis of distance to reach platform showed decrease over time,
which indicates that all animals had function to learn location of the
platform. Uninfected control animals learned significantly more quickly
than did survivors of meningitis ( ). Among these, treatmentP ! .001
with a-phenyl-tert-butyl nitrone (PBN) led to inferior performance,
compared with treatment with saline ( ).P ! .02
more frequent in the infected and PBN-treated animals than
in the infected, saline-treated group (median score, 1.15 [range,
0.04–1.73] vs. median score, 0.31 [range, 0–0.92]; ; fig-P ! .001
ure 3B). Uninfected animals, treated with PBN or saline,
showed neither cortical nor hippocampal injury.
Water maze experiment. All animals had normal vestibu-
lomotor function, as evidenced by their ability to stay on the
rotating rod. The distance to reach the platform decreased in
all 3 groups over time (figure 4), which indicated that all animals
had the capacity to learn the location of the platform. Unin-
fected control animals, however, learned significantly (P !
) more quickly than did the survivors of meningitis. Among.001
those, treatment with PBN, compared with treatment with sa-
line, led to a significantly inferior performance ( ). TheP ! .02
level of performance of uninfected animals on day 2 was ap-
proximated by infected and saline-treated animals on day 3 and
by infected and PBN-treated animals on day 4 only. Similar
results were obtained when we analyzed the time the animals
needed to reach the platform (figure 4), with a significant dif-
ference among all 3 groups ( ) and a trend for inferiorP ! .001
performance of the infected and PBN-treated group, compared
with that of the infected and saline-treated group ( ).P p .061
Discussion
The present study shows a detrimental effect of the radical
scavenger PBN in experimental S. pneumoniae meningitis, lead-
ing to an increase in hippocampal apoptosis and, in conse-
quence, to impaired learning function. This is the first report
to relate the severity of hippocampal apoptosis as a conse-
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quence of bacterial meningitis to reduced learning function in
the Morris water maze.
The histopathologic aspect of the cortical damage in men-
ingitis models with S. pneumoniae or GBS is usually a well-
demarcated wedge-shaped area of injury, which suggests an
ischemic mechanism caused by vasculitis and intravascular mi-
crothrombi. Production of ROS in the cortex during meningitis
seems to be caused by ischemia and reperfusion, which is similar
to the mechanisms in other brain diseases, such as brain con-
cussion or stroke, in which ROS are thought to be mediators
of injury [26–29]. Treatment with PBN, as well as other types
of antioxidants, proved to be beneficial in preventing micro-
vascular changes and cortical necrotic injury in various animal
models of meningitis, independent of the infecting pathogen
[20, 23, 30, 31].
The pathways that lead from bacterial invasion of the central
nervous system to hippocampal neuronal apoptosis in bacterial
meningitis are not well understood. The fact that PBN is neu-
roprotective for the hippocampus in GBS meningitis, whereas
it is neurotoxic in the present study of S. pneumoniae meningitis,
suggests that pathogens may interact via different pathways at
the level of cellular signaling and that, depending on the precise
nature of that interaction, scavenging of ROS by PBN favors
or attenuates apoptosis.
Two hypotheses may explain our observations. First, bac-
terial pathogens seem to interact differently with ROS. In our
present study, CSF titers of S. pneumoniae were similar in the
PBN and saline treatment groups, which indicates that their
growth remains unaffected by the presence of a potent anti-
oxidant in vivo. In contrast, the CSF titer of GBS in saline-
treated rats was 100-fold lower than that in PBN-treated ani-
mals at 18 h after infection, which suggests that ROS play a
role as a host defense mechanism against GBS [10]. Recently
it was shown that S. pneumoniae possess a distinct mechanism
that decreases measurable superoxide production during in-
cubation with stimulated neutrophils [32, 33]. The preservation
of a nonoxidative environment, for example, through produc-
tion of superoxide dismutase, might prevent the deactivation
of the S. pneumoniae–specific virulence factor pneumolysin [34,
35]. Moreover, apoptotic neuronal death involves several types
of cellular signaling mechanisms—such as glutamate receptors,
protein kinases, and transcription factors—which are all sen-
sitive to the redox status of the cell [36, 37]. Thus, combination
of antioxidant treatment and the presence of S. pneumoniae in
our model may create a reductive environment that favors vir-
ulent properties of S. pneumoniae and can directly lead to neu-
ronal death itself [37].
The second hypothesis relies on a direct pathogen-specific
signaling pathway via the recently discovered human toll-like
receptor (TLR). This is suggested by the finding that the human
TLR-2 is a signaling receptor for S. pneumoniae but not for
GBS [38, 39]. Human TLRs are transmembrane proteins that,
among other functions, are known to mediate translocation
and activation of NF-kB by gram-positive bacteria. PBN blocks
the predominantly antiapoptotic effect of NF-kB activation [40,
41] and may hence shift the balance from antiapoptotic to pro-
apoptotic signaling. Apart from NF-kB activation, TLR-2–
gated discrimination among different pathogens may account
for alternate signaling pathways with different susceptibility to
ROS. Discrimination among specific pathogens has been shown
elsewhere by the documentation of pathogen-dependent pat-
terns of cytokine activation in bacterial meningitis [42]. Thus,
the TLR pathway may ultimately determine the pro- or anti-
apoptotic effect of therapeutic intervention with antioxidants.
These opposite effects of the same agent depending on the
pathogen strongly suggest a critical interplay between microbial
and host factors, which are currently under investigation. We
suspect that the elucidation of these processes will lead to the
identification of novel factors important in the pathogenesis of
bacterial infections.
Neither increased nor decreased apoptosis has been observed
with other antioxidants given during S. pneumoniae meningitis
[23], which can be explained by the shorter circulatory half-life
and lower blood-brain barrier passage of these drugs, compared
with that of PBN.
In conclusion, we found that treatment with the radical scav-
enger PBN during S. pneumoniae meningitis in rat pups atten-
uated cortical necrosis but increased apoptotic neuronal death
in the hippocampus. This is in contrast to what was seen in
GBS meningitis, in which PBN protected neurons from both
forms of injury. Increased hippocampal damage by PBN led to
further decrease in learning function of survivors in the Morris
water maze. Antioxidant treatment is therefore not uniformly
beneficial in bacterial meningitis. Pathogen- and host-related
mechanisms that influence the redox status and transcription
factors of neuronal cells may be involved.
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